SEMAX
Russian nootropic peptide studied for raising neurotrophic factors (BDNF, NGF) and for its neuroprotective action.
Synthetic analog of the ACTH(4-10) fragment, developed in Russia as a nootropic. It is studied for its effect on the expression of neurotrophic factors such as BDNF and NGF, and for its neuroprotective activity at the transcriptomic level in cerebral ischemia models.
Benefits studied in research
- Studied for its effect on the expression of neurotrophic factors such as BDNF and NGF.
- Investigated for its role in cognitive function and memory processes in experimental models.
- Evaluated for its neuroprotective activity against stress conditions in preclinical models.
- In cerebral ischemia-reperfusion models, studied for neuroprotective effects at the transcriptomic level.
Key data
- Class
- Nootropic peptide (ACTH 4-10 analog)
- Markers
- BDNF · NGF
- Study focus
- Cognition · memory · neuroprotection
- Models
- Preclinical (ischemia, stress)
- Storage
- −20 °C lyophilized · 4 °C reconstituted
Scientific backing
Peer-reviewed publications on the molecule. Research references, not indications for use.
Reconstitution calculator
Adjust the values to plan your protocol. The vial's mg sync with the size you select above.
Calculation tool for laboratory planning (RUO). An insulin U-100 syringe has 100 units = 1 ml. Not a dosing recommendation.
Frequently asked questions
A peptide studied for its effect on cognitive processes. In this case, research focuses on the modulation of neurotrophic factors such as BDNF and NGF.
Beyond the lyophilized vial, it appears frequently in the literature in intranasal form in experimental models.
